Impact on public health

Data graphics, insights from leaders, and stories that illustrate the impact of COVID-19 on public health.

Featured Content

Article

The risks and challenges of the global COVID-19-vaccine rollout

– A realistic assessment of the heroic effort to administer billions of doses of COVID-19 vaccines to an agonized global population is necessary—the stakes could not be higher.

The emotional toll of COVID-19

Behavior health issues associated with anxiety, depression, and substance abuse are on the rise. Explore our collection of resources and insights on well-being.
Collection

Coronavirus vaccines progress: What’s next?

The rapid development of the COVID-19 vaccines is having a profound effect on the world. This collection takes a closer look at the development, rollout and future of vaccines.

Interactives

Interactive

How Americans feel about COVID-19 vaccinations

Over half the respondents in the United States report an interest in taking a COVID-19 vaccine though safety and efficacy concerns remain drivers for vaccine hesitancy.
Interactive

What’s behind physician burnout?

We surveyed US physicians about the concerns that may be contributing to their state of burnout during the COVID-19 crisis.
Interactive

Airflow considerations for businesses during the time of COVID-19

See what changes to heating, ventilation, and airflow systems could help limit viral spread in offices, retail stores, and manufacturing facilities.
Interactive

The prevalence of COVID-19 across the United States

Epidemiological data tracking the extent of the coronavirus outbreak and testing efforts
Interactive

COVID-19 case tracker

Epidemiological data on the pandemic, with global, country, and local views.
Interactive

Executive survey on returning to US workplaces amid COVID-19

A survey of US executives shows how companies are using safety measures to protect workers and customers amid COVID-19.
Interactive

Face-mask use in the United States

A series of McKinsey surveys explores Americans’ self-reported and perceived face-mask usage.

INSIGHTS

Article

NEF Spotlight: Global health in the post-COVID-19 era

– Bloomberg New Economy Forum and McKinsey & Company, Fall 2020
Article

Helping US healthcare stakeholders understand the human side of the COVID-19 crisis: McKinsey Consumer Healthcare Insights

– Healthcare stakeholders on the front lines of the COVID-19 pandemic must understand not only the disease itself, but also consumers’ questions, concerns, and behaviors. Our recent rapid-research effort in the US provides some early insights.
Article

Biopharma 2020: A landmark year and a reset for the future

– Biopharma in 2020 has shown what it can achieve when it works at its best. How can the industry build on this renewed sense of purpose in the years ahead?
Article

COVID-19 vaccines meet 100 million uncertain Americans

– More than 100 million Americans are uncertain about vaccination. Public- and private-sector leaders can take action to support adoption, including incremental investment in the range of $10 billion.
Article

Rebuilding clinician mental health and well-being after COVID-19

– The pandemic has exacerbated existing issues around the mental health of healthcare workers. Providers can learn from other industries to develop an integrated framework promoting overall well-being.
Article

COVID-19 and in vitro diagnostics: New market forces at play

– The high demand for in vitro diagnostics could seed structural shifts that will have long-term implications for diagnostic-test manufacturers.
Article

The COVID-19 vaccines are here: What comes next?

– Countries must prepare now for the largest simultaneous global public-health initiative ever undertaken.
Interview - McKinsey Quarterly

Speeding up to become even more consumer-obsessed: An interview with GSK’s Keith Choy

– The leader of GlaxoSmithKline’s Asia–Pacific Consumer Healthcare group describes how his organization is speeding up to serve consumers, despite the heightened uncertainty of COVID-19.
Article

Healthcare innovation: Building on gains made through the crisis

– Leaders should consider the lessons and achievements of the COVID-19 crisis in forging new innovation aspirations—and the mechanisms needed to execute them.
Article

Five ways to design a better mental-health future for a stressed-out workforce

– Almost 41 percent of Americans struggle with mental-health issues stemming from the COVID-19 pandemic, but many companies remain ill equipped to address the problem.
Interview

Building a healthcare ecosystem in India: A conversation with Shobana Kamineni

– The COVID-19 pandemic led to public-private partnerships that reflect the evolving nature of healthcare.
Article - McKinsey Global Institute

How prioritizing health is a prescription for US prosperity

– As the United States rebuilds its economy in the wake of the pandemic, investing in health can lead the way.
Journal Article

Clinical trial recovery from COVID-19 disruption

COVID-19 has caused unprecedented disruption of clinical trials and patient care. Our new paper in NRDD presents the 6 ongoing challenges ahead—both existing and new—for clinical trials, innovations to address them, and actions to maximize impact.
Article

Cutting through the COVID-19 surgical backlog

– COVID-19 has caused the deferral of millions of elective procedures, resulting in a potential backlog of case volume.
Article

Winter is coming: What’s next in COVID-19 testing

– The upcoming flu season in the Northern Hemisphere is expected to increase demand for COVID-19 testing. Decision makers may ask: Will there be enough flexible testing capacity to respond to global demand and avoid second lockdowns?
Article

Zero-based budgeting for health plans: Dealing with uncertainty ahead

– Zero-based budgeting may be the right recipe to deal with the cost control and flexibility needed in next year’s budgets.

Webinars

Webinar

COVID-19 vaccines are here. What does that mean for your organization?

– The COVID-19 vaccines have arrived but pressing questions remain on development, implications for the new strains, rollout challenges and the role companies can play in the worldwide vaccination effort.
Webinar

Behavioral health crisis in the United States: The fallout from the COVID-19 pandemic

– The adverse impact of COVID-19 on behavioral health—which comprises both mental health and substance use—presents additional challenges and opportunities for industry leaders.

Share your feedback and stay connected to the COVID Response Center

The contents of this site, including any statements, articles, graphics, charts, checklists, and other materials (“Content”) are for informational purposes only. The Content is not intended to be a substitute for professional advice or constitute medical advice.